This review highlights synthetic strategies to produce cannabinoids in cannabis sativa, suggesting advances in organometallic catalysts.
Cannabis sativa L., a genus of the Cannabis family, is an exclusive source of C21 terpenophenolic cannabinoids and an important class of bioactive compounds known for their health effects. Moreover, cannabinoids are found to exhibit remarkable properties in treating various ailments like rheumatism, asthma, glaucoma, fatigue, insomnia, nausea, and epilepsy. This review shares a broad interest in examining the detailed chemistry of significant cannabinoids—THC (tetrahydrocannabinol) and CBD (cannabidiol)—with respect to their synthetic advances using organometallic reagents and catalysis. The studies highlighted herein manifest the compilation of a range of metal reagents such as Au, Ru, Pd, Mo, Ir, Rh, Re, Cu, Ni, and Zn for generating cannabinoid natural products from simple building blocks, with emphasis on breakthroughs and potential for their constructive synthesis.
No takes yet. Share an insight, caveat, or question.
Chauhan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: